<span item_type="fundamental" item_id="1e6ede5f1f46c1330eb23589befb642f" counter_id="ST/US/NNE" env="prod"></span><span item_type="announcement" item_id="595000096507567745" env="prod"></span><p>Revenue: As of FY2025, the actual value is USD 0.</p><p>EPS: As of FY2025, the actual value is USD -1.06, beating the estimate of USD -1.1675.</p><p>EBIT: As of FY2025, the actual value is USD -51.78 M.</p><p></p><h3>Segment Revenue</h3><ul><li>The company is in the pre-revenue stage and has not generated any revenue from its inception through September 30, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1923891/000149315225028285/form10-k.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li><strong>Net Loss</strong>: The company reported a net loss of $40,067,076 for the year ended September 30, 2025, compared to a net loss of $10,151,556 for the year ended September 30, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1923891/000149315225028285/form10-k.htm"></span></li><li><strong>Research and Development Expenses</strong>: Increased by $11,720,948, or 315%, to $15,446,513 for the year ended September 30, 2025, primarily due to increased activities related to microreactor development.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1923891/000149315225028285/form10-k.htm"></span></li><li><strong>General and Administrative Expenses</strong>: Increased by $22,711,527, or 332%, to $29,562,520 for the year ended September 30, 2025, due to higher equity-based compensation and professional fees.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1923891/000149315225028285/form10-k.htm"></span></li></ul><h3>Cash Flow</h3><ul><li><strong>Operating Cash Flow</strong>: Net cash used in operating activities was - $19,621,963 for the year ended September 30, 2025, compared to - $8,464,146 for the year ended September 30, 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1923891/000149315225028285/form10-k.htm"></span></li><li><strong>Investing Activities</strong>: Net cash used in investing activities was - $17,524,377 for the year ended September 30, 2025, primarily due to acquisitions and property purchases.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1923891/000149315225028285/form10-k.htm"></span></li><li><strong>Financing Activities</strong>: Net cash provided by financing activities was $211,904,135 for the year ended September 30, 2025, mainly from equity financings and warrant exercises.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1923891/000149315225028285/form10-k.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li><strong>Equity-Based Compensation</strong>: Significant increase in equity-based compensation, with $5,597,010 in research and development and $13,227,205 in general and administrative expenses for the year ended September 30, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1923891/000149315225028285/form10-k.htm"></span></li></ul><h3>Outlook / Guidance</h3><ul><li>The company plans to continue developing its advanced reactors and vertically integrated business plan with estimated expenditures of approximately $65 million over the next twelve months.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1923891/000149315225028285/form10-k.htm"></span></li><li>The company anticipates submitting a construction permit application for the KRONOS MMR™ reactor in early 2026 and expects to receive the permit in 2027, although this timeline is subject to various uncertainties.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1923891/000149315225028285/form10-k.htm"></span></li></ul>

NANO Nuclear Energy | 10-K: FY2025 Revenue: USD 0